Study ID: Incyte BMS INCB24360-204 Advanced Tumors
A Phase 1/2 Study of the Safety, Tolerability, and Efficacy of INCB24360 Administered in Combination With Nivolumab in Select Advanced Cancers
Fargo Region, Sioux Falls Region
Steven Powell, MD,Amit Panwalkar, MD
Other, NHL (Non-Hodgkins Lymphoma)
Active - Open to Accrual
For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.